Aurobindo Pharma gets USFDA nod for oral suspension

Sevelamer Carbonate oral suspension is indicated for the control of serum phosphorus in patients with chronic kidney disease (CKD) on dialysis.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news